Literature DB >> 2966489

The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity.

B Singh1, C Wittenberg, M Hannink, S I Reed, D J Donoghue, R B Arlinghaus.   

Abstract

The viral mos gene encodes a cytoplasmic transforming protein termed p37mos. Evidence gathered from a number of experimental approaches is consistent with p37mos having a serine/threonine protein kinase activity. To gain further understanding of the p37mos-associated biochemical activity, we constructed a mutation in the v-mos gene by oligonucleotide-directed mutagenesis yielding a histidine to tyrosine substitution at residue 221 in p37mos. Based upon nucleotide sequences, the histidine residue at the corresponding position is conserved in all the serine/threonine protein kinases from yeast to man, and is absent in protein-tyrosine kinases. The mutant p37mos (Tyr-221) was expressed in yeast and assayed for kinase activity. The mutant protein was inactive as judged by a loss of autophosphorylation activity in vitro, thus providing further support for the conclusion that p37mos is a protein kinase. When the mutant v-mos gene was introduced into a retroviral vector, pDD102, and assayed for focus-forming ability on NIH/3T3 cells, it was found to be inactive at both 37 and 30 degrees. In contrast, the wild-type v-mos had transforming activity at both temperatures. These results extend our earlier findings on the correlation between transforming ability and protein kinase activity. A histidine to tyrosine substitution at the corresponding position of the v-mos protein and the yeast CDC28 gene product causes a similar effect on the kinase activity. Therefore, this residue and/or the sequence near the N-terminal side of the conserved predicted phosphate transfer domain, near the middle of the complete catalytic domain, might be specifically involved in the catalytic activity of serine/threonine protein kinases in general.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966489     DOI: 10.1016/0042-6822(88)90626-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation.

Authors:  R S Freeman; D J Donoghue
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

2.  mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities.

Authors:  N Yew; M Oskarsson; I Daar; D G Blair; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

3.  v-mos protein produced by in vitro translation has protein kinase activity.

Authors:  N K Herzog; M Nash; L S Ramagli; R B Arlinghaus
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  Inhibition of v-Mos kinase activity by protein kinase A.

Authors:  Y Yang; C H Herrmann; R B Arlinghaus; B Singh
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

5.  Casein kinase I-like protein kinases encoded by YCK1 and YCK2 are required for yeast morphogenesis.

Authors:  L C Robinson; M M Menold; S Garrett; M R Culbertson
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

6.  v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.

Authors:  B Singh; C Stocking; R Walker; Y D Yang; W Ostertag; R B Arlinghaus
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  A characterization of cytostatic factor activity from Xenopus eggs and c-mos-transformed cells.

Authors:  I Daar; R S Paules; G F Vande Woude
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

8.  Identification of protein tyrosine phosphatase 1B and casein as substrates for 124-v-Mos.

Authors:  Tassula Proikas-Cezanne; Silvia Stabel; Dieter Riethmacher
Journal:  BMC Biochem       Date:  2002-04-04       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.